SIGA Technologies Inc. (SIGA): Price and Financial Metrics
SIGA Price/Volume Stats
| Current price | $8.76 | 52-week high | $10.00 |
| Prev. close | $8.35 | 52-week low | $4.22 |
| Day low | $8.39 | Volume | 865,489 |
| Day high | $8.87 | Avg. volume | 695,773 |
| 50-day MA | $7.13 | Dividend yield | N/A |
| 200-day MA | $5.64 | Market Cap | 622.77M |
SIGA Stock Price Chart Interactive Chart >
SIGA Technologies Inc. (SIGA) Company Bio
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.
Latest SIGA News From Around the Web
Below are the latest news stories about SIGA TECHNOLOGIES INC that investors may wish to consider to help them evaluate SIGA as an investment opportunity.
Investors in SIGA Technologies (NASDAQ:SIGA) have unfortunately lost 44% over the last yearPassive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you... |
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023- In Third Quarter, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - In October, Joint Procurement Framework Contract was signed by European Commission with Anticipated Initial Orders by Participating Countries of Approximately $18 Million for Oral TPOXX® (Tecovirimat) - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-s |
SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial ResultsNEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, November 7th, 2023. Participating on the call will be Phil Gomez, Chief Executive Officer, Dennis Hruby, Chief Scientific Officer, Dr. Jay Varma, Chief Medical Officer and Daniel Luckshire, Chief Financial Officer. A live webcast of the |
SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating CountriesNEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced the creation by the European Commission’s DG HERA (Health Emergency Preparedness and Response Authority) of a joint procurement mechanism under which 13 participating countries from the European Union (EU) and the European Free Trade Association (EFTA) can efficiently order oral TPOXX. Based on commitments from |
The Zacks Analyst Blog Highlights Virco, G-III Apparel, SIGA Technologies, Lantronix and DuolingoVirco, G-III Apparel, SIGA Technologies, Lantronix and Duolingo are included in this Analyst Blog. |
SIGA Price Returns
| 1-mo | 0.00% |
| 3-mo | 73.12% |
| 6-mo | 69.44% |
| 1-year | 53.68% |
| 3-year | 22.35% |
| 5-year | 66.22% |
| YTD | 56.43% |
| 2023 | -23.91% |
| 2022 | -2.13% |
| 2021 | 3.44% |
| 2020 | 52.41% |
| 2019 | -39.62% |
Continue Researching SIGA
Here are a few links from around the web to help you further your research on Siga Technologies Inc's stock as an investment opportunity:Siga Technologies Inc (SIGA) Stock Price | Nasdaq
Siga Technologies Inc (SIGA) Stock Quote, History and News - Yahoo Finance
Siga Technologies Inc (SIGA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...